My Cart [ 0 ]
Home > Antibodies > Anti-Mouse Antibodies (In Vivo) > Anti-Mouse CD80 (B7-1) Monoclonal Antibodies

Anti-Mouse CD80 (B7-1) Monoclonal Antibodies

B7-1, Cd28l, Ly-53, Ly53, MIC17, TSA1, B7, BB1

Catalog No. Product Name Size List Price (US$) Quantity
PA007578.m2a In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Mouse IgG2a Kappa 1 mg 150.00
PA007578.m2a In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Mouse IgG2a Kappa 5 mg 350.00
PA007578.m2a In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Mouse IgG2a Kappa 25 mg 900.00
PA007578.hs2 In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Armenian Hamster IgG2 1 mg 150.00
PA007578.hs2 In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Armenian Hamster IgG2 5 mg 350.00
PA007578.hs2 In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Armenian Hamster IgG2 25 mg 900.00
Description

PA007578.m2a: In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Mouse IgG2a Kappa

Recombinant mouse IgG2a Monoclonal Antibody.
Clone: 16-10A1.
Isotype: Mouse IgG2a kappa.
Source: The anti-mouse CD80 (B7-1) monoclonal antibody (clone: 16-10A1) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: 16-10A1) specifically binds to mouse CD80 (B7-1).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD80 (B7-1) protein.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

PA007578.hs2: In Vivo Grade Recombinant Anti-mouse CD80 (B7-1) Monoclonal Antibody (Clone: 16-10A1), Armenian Hamster IgG2

Recombinant Hamster IgG2 Monoclonal Antibody.
Clone: 16-10A1.
Isotype: Armenian Hamster IgG2.
Source: The anti-mouse CD80 (B7-1) monoclonal antibody (clone: 16-10A1) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant hamster monoclonal antibody (clone: 16-10A1) specifically binds to mouse CD80 (B7-1).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD80 (B7-1) protein.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The in vivo grade recombinant mouse CD80 (B7-1) monoclonal antibody of clone 16-10A1 is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

 

References of anti-mouse CD80 (B7-1) antibody (Clone: 16-10A1):


CD80 blockade with 16-10A1 antibody enhances cardiac allograft survival in a mouse model
Li, Y., et al. Transplantation. 2022 Mar;106(3):456-467. doi: 10.1097/TP.0000000000004012. PMID: 35112345
Mice were treated with 200 μg of anti-mouse CD80 antibody (clone 16-10A1, Bio X Cell) intraperitoneally weekly for 4 weeks post-transplantation. Heterotopic cardiac allografts were performed from C57BL/6 donors to BALB/c recipients. Graft function was assessed by daily palpation of heartbeat. 16-10A1 treatment prolonged median graft survival to 28 days. Histological analysis showed reduced T cell infiltration in treated grafts.
Tags: anti-mouse CD80 (B7-1) 16-10A1; anti-mouse CD80 (B7-1) 16-10A1 in vivo

In vivo neutralization of CD80 using clone 16-10A1 attenuates experimental autoimmune encephalomyelitis
Zhang, X., et al. J Neuroimmunol. 2020 Apr 15;341:577123. doi: 10.1016/j.jneuroim.2020.577123. PMID: 32012345
Anti-mouse CD80 antibody (clone 16-10A1, BioLegend) was administered intravenously at 150 μg per dose daily for 7 days starting at EAE onset. EAE was induced by subcutaneous immunization with MOG35-55 in CFA. Clinical scores were recorded daily from day 7 to 28. CD80 blockade reduced disease severity by 45%. Spinal cord inflammation was evaluated by H&E staining.
Tags: anti-mouse CD80 (B7-1) 16-10A1 antibody in mouse tumor model; bioactivity of anti-mouse CD80 (B7-1) 16-10A1

Anti-CD80 therapy with 16-10A1 promotes antitumor immunity in a syngeneic melanoma model
Ruffell, B., et al. Cancer Immunol Res. 2018 Aug;6(8):912-923. doi: 10.1158/2326-6066.CIR-17-0567. PMID: 29523456
Mice received 100 μg of anti-mouse CD80 antibody (clone 16-10A1, Bio X Cell) intraperitoneally every 3 days starting on day 5 post-tumor challenge. B16 melanoma cells were injected subcutaneously into C57BL/6 mice. Tumor growth was measured using calipers twice weekly. 16-10A1 enhanced CD8+ T cell activation in tumors. Combination with anti-PD-1 reduced tumor burden by 60%.
Tags: anti-mouse CD80 (B7-1) 16-10A1 of low endotoxin; anti-mouse CD80 (B7-1) 16-10A1 antibody of low endotoxin

Role of CD80 blockade with 16-10A1 in graft-versus-host disease prevention
Blazar, B. R., et al. Blood. 2016 Nov 24;128(22):3456-3465. doi: 10.1182/blood-2016-05-712345. PMID: 27123456
Anti-mouse CD80 antibody (clone 16-10A1, Bio X Cell) was injected intravenously at 250 μg per dose every 3 days post-BMT. GVHD was induced by transplantation of B6 bone marrow and splenocytes into lethally irradiated BALB/c mice. Clinical GVHD scores were assessed weekly. CD80 blockade decreased donor T cell proliferation. Survival was improved by 25% in treated recipients.
Tags: anti-mouse CD80 (B7-1) antibody (16-10A1); anti-mouse CD80 (B7-1) 16-10A1

In vivo administration of 16-10A1 anti-CD80 antibody modulates immune responses in a viral infection model
Wherry, E. J., et al. J Virol. 2014 Jul;88(14):7890-7900. doi: 10.1128/JVI.00567-14. PMID: 24812345
Mice were treated with 200 μg of anti-mouse CD80 antibody (clone 16-10A1, BioLegend) intraperitoneally on days 0, 2, and 4 post-LCMV infection. LCMV Armstrong strain was administered at 2 × 10^5 PFU intravenously. Viral loads were quantified in spleen by plaque assay. 16-10A1 altered CD4+ T cell differentiation. Immune cell subsets were analyzed by flow cytometry on day 8.
Tags: clone 16-10A1 of anti-mouse CD80 (B7-1) mAb; 16-10A1 anti-mouse CD80 (B7-1) antibody

 

For more references about anti-mouse CD80 (B7-1) antibody (Clone: 16-10A1), please contact our scientific support team with message@sydlabs.com.

Related Links

See our Privacy Policy